Sight Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-55.55	-86.24	-62.96	-34.69	-25.87	-14.29
Depreciation & Amortization	1.62	1.25	1.2	1.12	0.43	0.06
Share-Based Compensation	14.58	12.96	5.08	0.5	0.12	0.05
Other Operating Activities	-7.84	-3.94	4.14	0.91	0.32	-0.3
Operating Cash Flow	-47.18	-75.97	-52.54	-32.17	-25	-14.48
Capital Expenditures	-0.79	-0.97	-0.81	-0.95	-0.67	-0.57
Investing Cash Flow	-0.79	-0.97	-0.81	-0.95	-0.67	-0.57
Share Issuance / Repurchase	1.33	1.25	257.04	0.03	0.03	0.02
Debt Issued / Paid	0	0	0	20.34	12.53	0
Other Financing Activities	-0.22	-	-4.51	53.03	30.1	12.18
Financing Cash Flow	1.1	1.25	252.53	73.4	42.66	12.2
Net Cash Flow	-46.87	-75.69	199.18	40.27	17	-2.84
Free Cash Flow	-47.98	-76.94	-53.35	-33.13	-25.67	-15.05
Free Cash Flow Margin	-59.19%	-107.86%	-108.98%	-119.85%	-109.94%	-199.80%
Free Cash Flow Per Share	-0.99	-1.61	-2.00	-3.54	-2.73	-1.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).